Acupath Laboratories, Inc.

04/15/2026

Our own COO, Brian Kunkel discusses our partnering journey with Lumea and the positive impact on Acupath and the clients and patients we serve.

LUMEA - How Acupath Laboratories Inc. is scaling diagnostic excellence.

In 1995, Acupath Laboratories began as a specialized dermatology lab. Fast forward to today: they are a triple-accredited powerhouse processing 300,000 biopsies a year for over 700 clients nationwide.

But how do you maintain that kind of scale without sacrificing speed or quality?

The answer: A strategic leap into full digital pathology.

We sat down with Brian Kunkel, COO of Acupath, to discuss their journey. By partnering with Lumea, Acupath didn't just upgrade their tech, they removed geographic barriers, accelerated reflex testing, and built a workflow that prioritizes clinical urgency over courier schedules.

"It’s an all-around improvement tool. Costing, efficiencies, growth, and diagnoses—it just checks off all the boxes." said Brian Kunkel.

Check out the full story of how Acupath is using digital tools to deliver faster, more accurate results for patients from New York to California.

Read the full story here: https://lnkd.in/dUsdfthj

04/07/2026

We're Hiring, come join our team!

Reception - Client Services Representative - Insurance Verification Specialist

Please visit our website or Indeed Job Postings for job descriptions, salary ranges, and to apply.

https://www.acupath.com/careers/

https://www.indeed.com/jobs?q=acupath+laboratories&latLong=40.67903%2C-73.53440&locString=Bellmore%2C+NY%2C+11710&from=searchOnHP%2Cwhatautocomplete%2CwhatautocompleteSourceStandard&vjk=beac36793d2ac07b

03/04/2026

🌸 March Cancer Awareness 🌸

This March, we stand together — for the fighters, the survivors, and the ones we’ve lost. 💜 Every voice matters, every story inspires, and every step brings us closer to a cure.

✨ Let’s spread awareness.

✨ Let’s show compassion.

✨ Let’s never stop believing in hope.

02/27/2026

February 27, 2026, PLAINVIEW, NY - Acupath Laboratories, Inc., Partners with Azer Scientific to Install the First AzerView Digital Pathology Scanner in the United States

https://www.businesswire.com/news/home/20260227598476/en/Acupath-Laboratories-Inc.-Partners-with-Azer-Scientific-to-Install-the-First-AzerView-Digital-Pathology-Scanner-in-the-United-States

02/10/2026

Acupath Systems Will be Down Temporarily for Database Maintenance, this Sunday, February 15, 2026, 12:30 AM - 8:30 AM.
Please check our website for any schedule updates. Thank you.

10/13/2025

Every slide tells a story. 🧬 Precision isn’t optional - it’s essential.
That’s why we rely on the Ventana IHC stainer for accuracy in every case.
🔬 Consistent results.
⚡ Faster turnaround.
💙 Better patient care.

10/01/2025

This October, let's unite for and awareness. Your health matters! Be proactive with self-exams and regular check-ups. Find support and share your story. You're not alone in this fight. Learn the risks and share the message to help save lives.

08/29/2025

Have a safe and Happy Labor Day!

03/24/2025

Lumea, AIRA Matrix, and Acupath have Partnered to Provide a Diagnostic AI Solution for the URO17® Bladder Cancer Biomarker

LEHI, UT, UNITED STATES, March 20, 2025 /EINPresswire.com/ — Lumea, a leader in digital pathology solutions. AIRA Matrix Private Limited, an innovative technology company for AI-based diagnostic, prognostic, and predictive applications in cancer care. Acupath, a leading provider of sub-specialized anatomic and molecular pathology services. These companies have joined forces to deliver an AI-based solution to assist in the diagnosis of urinary bladder cancers through cytopathological examination.

Read more:

Lumea, AIRA Matrix, and Acupath have partnered to provide a Diagnostic AI Solution for the URO17® Bladder Cancer Biomarker. Read more...

01/07/2025

The American Cancer Society's estimates for cervical cancer in the United States for 2024 were:

About 13,820 new cases of invasive cervical cancer will be diagnosed.

About 4,360 women will die from cervical cancer.
Cervical pre-cancers are diagnosed far more often than invasive cervical cancer.

Cervical cancer is most frequently diagnosed in women between the ages of 35 and 44, with the average age being 50. It rarely develops in women younger than 20.

Many older women don't realize that they are still at risk of developing cervical cancer as they age. More than 20% of cervical cancers are found in women over 65. However, these cancers rarely occur in women who have been getting regular tests to screen for cervical cancer before they were 65.

As always, screening is a key to diagnose any cancer, especially cervical, in the beginning stages.

For more information: https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.html

12/20/2024

The Annual Acupath Ugly Sweater Contest 2024...and they did not disappoint!!! Thank you to our staff for your participation and for always being team players! Happy Holidays!
Congratulations to Jenny for winning the coveted "Ugly Sweater 2024"!